| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |